Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Industry group responds to Dutch Minister’s 'something’s gotta give' reaction to drug price increases

A Dutch biopharma trade group has proposed a summit with the government on drug price transparency in response to Minister of Health Bruno Bruins’ threat to name and shame companies that excessively raise drug prices. The move by Bruins was intended to spur companies to be more transparent in their drug pricing and justify

Read the full 546 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers